Antigon | We revolutionize IVD testing

Not available for sale. Regulatory approval pending.

Not available for sale.
Regulatory approval pending.

Do you want to know more about ISABO™ ?

ISABO™

Ultimate Safety
and Traceability in Transfusion

DOUBLE VERIFICATION AT BEDSIDE

Patient/bag ABO groups and Rh-D verification.
Electronic patient ID/bag verification.

BENEFITS

Fast and intuitive process for transfusion staff.
Ultimate safety for patient and institution by reducing ABO bedside errors.
Full bag and patient traceability up to bedside.
Haemovigilance compliance.
Seamless IT connection with LIS through embedded Ethernet middleware protocol.

± 3 min ABO group and ID verification at bedside

ISABO™ is a Point-Of-Care Testing (POCT) device able to, automatically perform an ABO-D compatibility test at the patient bedside with 100 % reliability.

ISABO™ is intended to confirm patient and blood bag identity, in order to control ABO-D blood groups at patient bedside immediately before a transfusion.

The test is the confirmation of earlier blood bank ABO- and D-blood typing of the recipient. It ensures the compatibility of blood types of the recipient and the blood to be transfused just before transfusion at bedside.

“Based on 2 patents from ULB, ANTIGON is currently developing, with a consortium of regional and international partners/subcontractors, a first disruptive ABO POCT device aiming to improve drastically transfusion safety at bedside.”

Thierry Baltus, CEO

Fast biological test principle

The test uses principle of hemagglutination combined to filtration promoted by centrifugation.
Three blood group antigens (A, B and RhD) can be assessed simultaneously in separate test units on two different blood samples.
A negative control is included for each test.
Consumable disks (patent pending*) (transfer system included) can be stored at room temperature.

Key features

System for the reading of barcodes of bag and patient.
System for the identification of users through their RFID badge.
Capable to manage minimum 10 patients simultaneously with associated blood bags.
Autonomy of at least 8 hours (in full use).
Charged and connected to hospital IT/LIS through Ethernet via its docking station.
Each device upgrades are synchronized with the middleware and applied to all other instruments of the hospital.